These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 21226279)

  • 41. Vaccination to modulate atherosclerosis.
    Kimura T; Tse K; Sette A; Ley K
    Autoimmunity; 2015 May; 48(3):152-60. PubMed ID: 25683179
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The intravenous injection of oxidized LDL- or Apolipoprotein B100--Coupled splenocytes promotes Th1 polarization in wildtype and Apolipoprotein E--Deficient mice.
    Steinmetz M; Ponnuswamy P; Laurans L; Esposito B; Tedgui A; Mallat Z
    Biochem Biophys Res Commun; 2015 Aug; 464(1):306-11. PubMed ID: 26116775
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oral anti-CD3 immunotherapy for HCV-nonresponders is safe, promotes regulatory T cells and decreases viral load and liver enzyme levels: results of a phase-2a placebo-controlled trial.
    Halota W; Ferenci P; Kozielewicz D; Dybowska D; Lisovoder N; Samira S; Shalit I; Ellis R; Ilan Y
    J Viral Hepat; 2015 Aug; 22(8):651-7. PubMed ID: 25412903
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anti-inflammatory and immune-modulatory therapies for preventing atherosclerotic cardiovascular disease.
    Yamashita T; Sasaki N; Kasahara K; Hirata K
    J Cardiol; 2015 Jul; 66(1):1-8. PubMed ID: 25744783
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Vaccination against atherosclerosis? Induction of atheroprotective immunity.
    Hansson GK; Nilsson J
    Semin Immunopathol; 2009 Jun; 31(1):95-101. PubMed ID: 19468734
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adaptive immunity in atherogenesis: new insights and therapeutic approaches.
    Lichtman AH; Binder CJ; Tsimikas S; Witztum JL
    J Clin Invest; 2013 Jan; 123(1):27-36. PubMed ID: 23281407
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cytokines, macrophage lipid metabolism and foam cells: implications for cardiovascular disease therapy.
    McLaren JE; Michael DR; Ashlin TG; Ramji DP
    Prog Lipid Res; 2011 Oct; 50(4):331-47. PubMed ID: 21601592
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reality of a Vaccine in the Prevention and Treatment of Atherosclerosis.
    García-González V; Delgado-Coello B; Pérez-Torres A; Mas-Oliva J
    Arch Med Res; 2015 Jul; 46(5):427-37. PubMed ID: 26100340
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vaccination for atherosclerosis: a novel therapeutic paradigm.
    Shah PK; Chyu KY; Fredrikson GN; Nilsson J
    Expert Rev Vaccines; 2004 Dec; 3(6):711-6. PubMed ID: 15606356
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Atherosclerosis and the role of inflammation].
    Tokgözoğlu L
    Turk Kardiyol Dern Ars; 2009 Apr; 37 Suppl 4():1-6. PubMed ID: 19553755
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The role of T-regulatory cells in the pathogenesis of immunological disturbances accompanying obesity and atherosclerosis].
    Luczyński W; Bossowski A; Głowińska-Olszewska B; Kos J; Stasiak-Barmuta A
    Postepy Hig Med Dosw (Online); 2010 Mar; 64():156-60. PubMed ID: 20354263
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Immune cells in atherosclerosis--good or bad?].
    Klingenberg R; Matter CM; Lüscher TF
    Praxis (Bern 1994); 2016 Apr; 105(8):437-44. PubMed ID: 27078727
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intranasal immunization with heat shock protein 60 induces CD4(+) CD25(+) GARP(+) and type 1 regulatory T cells and inhibits early atherosclerosis.
    Zhong Y; Tang H; Wang X; Zeng Q; Liu Y; Zhao XI; Yu K; Shi H; Zhu R; Mao X
    Clin Exp Immunol; 2016 Mar; 183(3):452-68. PubMed ID: 26452441
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Measles virus nucleoprotein induces a regulatory immune response and reduces atherosclerosis in mice.
    Ait-Oufella H; Horvat B; Kerdiles Y; Herbin O; Gourdy P; Khallou-Laschet J; Merval R; Esposito B; Tedgui A; Mallat Z
    Circulation; 2007 Oct; 116(15):1707-13. PubMed ID: 17875970
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vaccines against atherosclerosis.
    Nilsson J; Wigren M; Shah PK
    Expert Rev Vaccines; 2013 Mar; 12(3):311-21. PubMed ID: 23496670
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Crosstalk Between Enzyme Matrix Metalloproteinases 2 and 9 and Regulatory T Cell Immunity in the Global Burden of Atherosclerosis.
    Lekic A; Brekalo Z; Kvesic A; Kovacevic M; Baricev-Novakovic Z; Sutic I; Bulog A; Sutic I; Pavisic V; Mrakovcic-Sutic I
    Scand J Immunol; 2017 Jul; 86(1):65-71. PubMed ID: 28500763
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vaccination, atherosclerosis and systemic lupus erythematosus.
    Carvalho JF; Pereira RM; Shoenfeld Y
    Lupus; 2009 Nov; 18(13):1209-12. PubMed ID: 19880570
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tolerization against atherosclerosis using heat shock protein 60.
    Wick C
    Cell Stress Chaperones; 2016 Mar; 21(2):201-11. PubMed ID: 26577462
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mast cells in atherosclerosis.
    Bot I; Biessen EA
    Thromb Haemost; 2011 Nov; 106(5):820-6. PubMed ID: 21866302
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Blockade of Tim-1 and Tim-4 Enhances Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient Mice.
    Foks AC; Engelbertsen D; Kuperwaser F; Alberts-Grill N; Gonen A; Witztum JL; Lederer J; Jarolim P; DeKruyff RH; Freeman GJ; Lichtman AH
    Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):456-65. PubMed ID: 26821944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.